Vice President, Strategy & Business Development - Advanced Therapeutics Division

Agilent Technologies•Boston, MA

5d•$280,000 - $481,250•Hybrid

About The Position

Agilent is seeking an enterprise leader for its Advanced Therapeutics Division (ATD), a specialty CDMO platform encompassing RNA oligonucleotide manufacturing in Colorado and BioVectra in Canada. The approximately $600 million business serves pharmaceutical and biotechnology customers from early development through commercial-scale manufacturing and is a significant growth platform. The Vice President, Strategy and Business Development is an enterprise executive with full P&L accountability and end-to-end responsibility for the division’s growth, performance, and strategic development. The role spans commercial growth, portfolio and technology strategy, early R&D, strategic marketing, customer alliances, capital allocation, and M&A. The leader will determine where Agilent competes, build a predictable revenue pipeline, focus resources on compelling opportunities, and develop an integrated organization for sustained, profitable growth. The role connects strategy and customer commitments to capacity, technical delivery, quality, and economics. The position leads a geographically distributed, cross-functional organization and works across a complex global matrix. It is based in Santa Clara, California, with additional Agilent sites and remote work considered. Travel is occasional. The position is full-time, with a day shift and no end date. The stated pay range is $280,000–$481,250 per year, plus eligibility for bonus, stock, and benefits.

Requirements

At least 15 years of progressive leadership experience in CDMO, biopharma manufacturing, life-sciences tools or services, or a closely related sector, including significant executive responsibility.
Demonstrated accountability for commercial growth and meaningful financial outcomes at scale.
Broad understanding of pharmaceutical and biotechnology customers and the scientific, regulatory, quality, and economic dynamics of development and manufacturing.
Relevant exposure to nucleic-acid therapeutics, oligonucleotides, RNA, biologics, APIs, peptides, complex chemistry, or other advanced therapeutic modalities.
Demonstrated success in business development, strategic-account leadership, and creating and converting complex, high-value revenue pipelines.
Meaningful leadership across portfolio strategy, strategic marketing, early R&D, or technology choices, with a record of translating market insight into investment priorities.
Operational fluency, including understanding capacity, technical transfer, program delivery, quality, productivity, and capital tradeoffs.
Direct experience with major organic capital decisions and meaningful involvement in M&A, partnerships, diligence, and integration.
Ability to integrate resources across a large global matrix and influence executive stakeholders who are not direct reports.
Bachelor’s degree in a relevant scientific, engineering, or business discipline.
Enterprise-minded and accountable leadership; commercial and strategic sophistication; decisiveness and resilience; collaboration and influence; data- and process-oriented decision-making; and the ability to develop leaders.

Nice To Haves

Full P&L ownership; comparable responsibility for a major business, portfolio, commercial function, or growth agenda will also be considered.
Direct oligonucleotide experience.
Advanced scientific, engineering, or business degree.

Responsibilities

Own ATD’s full P&L and overall performance, including revenue growth, profitability, margin expansion, cash generation, and return on invested capital.
Set and evolve the multiyear growth agenda, translating strategy into operating priorities, resource decisions, and measurable outcomes.
Establish a data- and KPI-based operating cadence across the commercial pipeline, program execution, productivity, innovation, quality, and financial performance.
Own the global business-development strategy and revenue pipeline, from market development and lead generation through qualification, contracting, program award, scale-up, and commercial handoff.
Build a systematic, data-driven commercial engine to improve pipeline quality, deal velocity, conversion, forecast accuracy, and strategic-account expansion.
Develop senior pharmaceutical and biotechnology customer relationships, personally lead consequential opportunities, and align customer commitments with capability, capacity, quality, capital needs, and long-term economics.
Build alliances with customers, technology partners, and platform collaborators, and represent Agilent at customer engagements, industry forums, and scientific conferences.
Translate customer, scientific, and market insights into portfolio, R&D, and investment decisions.
Define portfolio strategy across RNA oligonucleotides, BioVectra, and relevant adjacent modalities; identify opportunities for differentiated, defensible leadership.
Oversee early-stage R&D and technology investment priorities and ensure innovation addresses customer needs and commercially attractive emerging modalities.
Own strategic marketing, segmentation, positioning, and market development; assess modality mix, service-line expansion, capacity needs, and technology evolution.
Drive strategic capital allocation across manufacturing capacity, technology platforms, R&D, and commercial capability in collaboration with Global Operations.
Identify and develop acquisitions, partnerships, licensing opportunities, and other strategic investments; build business cases and secure alignment across Agilent leadership, Finance, and Corporate Development.
Co-lead the strategic and organizational integration of acquired businesses and capabilities and deliver their growth and value-creation objectives.
Lead and develop a geographically distributed organization spanning portfolio strategy, business development, early R&D, marketing, and support functions.
Integrate the Colorado and BioVectra businesses while preserving their speed, expertise, and customer responsiveness.
Build alignment across the global matrix and partner with Operations, Quality, Regulatory, Finance, HR, Legal, Corporate Development, and other functions.
Attract and develop talent, build succession depth, and foster customer focus, accountability, collaboration, scientific curiosity, and continuous improvement.